H.Res. 484 is a symbolic resolution expressing congressional support for designating the first week of June as "Hidradenitis Suppurativa Awareness Week." Hidradenitis Suppurativa (HS) is a chronic inflammatory skin disease affecting approximately 3.3 million Americans that causes painful boils, abscesses, scarring, and significant psychological distress—including an elevated suicide rate among dermatological conditions. The resolution highlights that 75 percent of HS patients are misdiagnosed or not diagnosed until after age 25, which delays critical treatment and worsens outcomes and healthcare costs. The resolution calls on Congress to recognize the importance of increasing public awareness, improving diagnosis and screening, supporting research into the disease, accelerating treatment development, and addressing disparities in access to care. This is a non-binding resolution with no direct funding or implementation timeline, serving primarily to bring attention to HS and encourage federal action on research and patient care improvements.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.